Packages

16 utilities covering the Tc-99m renal workflow: generator eluate and Mo-99 breakthrough, Sn(II), labeling stoichiometry and pH, radiochemical purity and stability of MAG3, DTPA, DMSA(III) and glucoheptonate, gamma-camera uniformity, renal uptake and plasma clearance, bladder voiding efficiency, patient dosimetry and decay-in-storage waste management.

36 utilities for clinically oriented radiopharmaceutical and workflow quality control: PET/SPECT tracers, the Tc-99m renal workflow, PRRT, PSMA therapy, targeted alpha therapy, radioembolization, bone-pain palliation, immuno-PET and generator-based radionuclide control.

A curated set of new utilities for radionuclide control, targeted alpha therapy, specific activity, radiolysis stability and preliminary dosimetry calculations.

A curated suite for PET/SPECT radiopharmaceuticals, generator and cyclotron radionuclides, labelled compounds, radiochemical purity, breakthrough, sterility and endotoxin control.

Quality control of Tc-99m MAA, particle size and count, suspension stability, lung perfusion studies, lung-shunt estimation, pre-therapy dosimetry and concordance with Y-90 distribution.

Quality control of HIDA, mebrofenin and disofenin, hepatic extraction and gallbladder ejection calculations, and hepatobiliary transit review.

Tc-99m HMPAO leukocyte labelling, labelling efficiency, cell viability and recovery, free activity, process time and temperature, and pre-reinjection release.

Sodium pertechnetate Tc-99m quality control and thyroid, salivary-gland, Meckel diverticulum and ectopic gastric-mucosa imaging workflows.

Red-cell mass and blood-volume calculations, Cr-51 labelling efficiency, elution correction, recovery-curve analysis and sample-timing control.

Gastric-emptying and GI-transit review, labelled-RBC gastrointestinal bleeding scintigraphy and Tc-99m colloid liver/spleen studies.

Tc-99m DTPA aerosol and Technegas control, aerosol-deposition review, V/Q mismatch evaluation and V/Q acquisition completeness.

Tc-99m nanocolloid and tilmanocept control, injection review, acquisition QC, node-detection threshold and shine-through assessment.

In-111 and Tc-99m platelet labelling, cell recovery, autologous-cell release and cell-viability control.

Ga-67 citrate, Tc-99m sulesomab and Tc-99m besilesomab control, plus antigranulocyte imaging acquisition review.

Renal radiopharmaceuticals and calculation workflows: MAG3, DTPA, DMSA, glucoheptonate, generator Tc-99m, dynamic renography, GFR/ERPF and dosimetry.

Macroaggregated albumin: particle size and count, radiochemical purity, resuspension, lung perfusion, lung shunt and pre-therapy Y-90 planning.

Hepatobiliary tracers, pertechnetate for Meckel/gastric mucosa, gastric emptying, GI transit, RBC bleeding and liver/spleen sulfur colloid.

Leukocytes, red blood cells, platelets and autologous cell workflows: labeling efficiency, viability, free activity, recovery and release before reinjection.

Pertechnetate as a standalone radiopharmaceutical and starting material: thyroid uptake, salivary glands, Meckel scan, gastric mucosa and generator/eluate control.

Sestamibi, tetrofosmin, MDP, pyrophosphate, thallium and related quality checks for cardiology, bone imaging and classic SPECT protocols.

F-18, Ga-68, Cu-64, Zr-89, In-111 and other diagnostic tracers: synthesis, purity, receptor targeting, immuno-PET and generator-based workflows.

Lu-177, Ac-225, Ra-223, Y-90, Ho-166, Sm-153, Sr-89, Re-188, Tb-161, I-131 and other therapeutic radiopharmaceuticals: activity, purity, free metal, daughters and toxicological constraints.

Control of generator eluate, breakthrough, radionuclidic purity, isotope mix, carrier/free radionuclides and starting radionuclides before labeling.

Xe-129, Xe-133, Xe-127, hyperpolarization, SEOP, T1, mixing, scavenging, transport, recovery and ventilation imaging.

The linked medical-device/radiation-physics layer: PET detector QC, normalization, AC map, cross-calibration, TOF, gamma-camera uniformity, source strength and staff dose.

Tc-99m radiopharmaceuticals, kit preparation, generator control, SPECT workflows and calculation utilities.

F-18, C-11, N-13, O-15 and related PET production, release and imaging workflows.

Ga-67, Ga-68 and Ge-68: generator, radiolabelling, PET/SPECT and purity workflows.

I-123, I-124, I-125 and I-131 for diagnostics, therapy, labelling and purity control.

Lu-177, Y-90, Ho-166, Re-188, Sm-153, Sr-89, P-32, Cu-67 and Tb-161.

Ac-225, Ra-223, At-211, Bi-213 and Th-227: targeted alpha therapy and daughter/recoil control.

Cu-64, Zr-89, I-124, Mn-52 and Y-86 for antibodies, slow kinetics and extended imaging.

In-111 and Cr-51 for labelled cells, blood volume, RBC/WBC and survival workflows.

Rb-82/Sr-82, N-13 and Tl-201 for myocardial perfusion and generator-supported workflows.

Xe-127, Xe-129 and Xe-133 for ventilation, hyperpolarized imaging, gas QC and safety.

Renography, GFR/ERPF, renal uptake, DMSA/MAG3/DTPA and bladder-related workflows.

Lung perfusion, MAA, V/Q, aerosol, xenon ventilation, shunt and pulmonary dosimetry.

HIDA, mebrofenin, gallbladder, gastric emptying, GI transit, bleeding and liver/spleen imaging.

Myocardial perfusion, cardiac PET/SPECT, ventricular function, blood-pool and perfusion tracers.

Brain perfusion, dopamine transporter, amyloid/tau, receptor imaging and neurological SPECT/PET.

Radioiodine, thyroid/parathyroid, somatostatin receptor, MIBG and neuroendocrine workflows.

Bone scintigraphy, MDP/PYP, marrow, bone-pain palliation, skeletal metastases and radiosynovectomy.

WBC/RBC/platelet labelling, blood volume, survival, blood-pool and cellular release workflows.

Sentinel node, lymphoscintigraphy, nanocolloid, labelled leukocytes, granulocyte and inflammatory imaging.

Tumour imaging, PSMA/FAPI/receptor tracers, immuno-PET, targeted radionuclide therapy and radioembolization.

Radiolabelling, synthesis, chelation, reducing agent, pH/stoichiometry and kit preparation.

Assay, purity, sterility, endotoxins, pH, impurities, appearance and batch-release checks.

Generator eluate, breakthrough, radionuclidic purity, isotope mix and starting radionuclides.

Activity planning, absorbed dose, organ dose, lung shunt, preplanning and therapy verification.

Acquisition, uptake, clearance, perfusion, transit, ejection fraction, segmentation and quantitative imaging.

Kinetic stability, shelf life, decay correction, expiry, storage, trend and radioactive waste.

PET/gamma-camera state, calibration, detector QC, energy window, TOF, shielding and radiation safety.